(Press-News.org) Contact information: Irene Sege
irene.sege@childrens.harvard.edu
617-919-3110
Boston Children's Hospital
Researchers build muscle in diseased mice; create human muscle cells in a dish
New zebrafish technique quickly finds potential treatments for multiple diseases
Skeletal muscle has proved to be very difficult to grow in patients with muscular dystrophy and other disorders that degrade and weaken muscle. Researchers at Boston Children's Hospital's Stem Cell Program now report boosting muscle mass and reversing disease in a mouse model of Duchenne muscular dystrophy, using a "cocktail" of three compounds identified through a new rapid culture system. Adding the same compounds to stem cells derived from patients' skin cells, they then successfully grew human muscle cells in a dish.
Senior investigator Leonard Zon, MD, director of the Stem Cell Program at Boston Children's and an investigator with the Howard Hughes Medical Institute, hopes for clinical trials to begin transplanting these cells into patients with muscle loss in the next several years. In the meantime, the screening technique, described in the journal Cell (published online November 7), can also be applied to multiple disorders beyond muscular dystrophy, he says.
#1: Zebrafish
The drug screening technique begins with zebrafish. Zon and colleagues placed tiny zebrafish blastomeres—cells from very early stage embryos—into 384-well culture dishes, adding one test compound to each well. This allowed them to screen 2,400 compounds at once, seeking ones that boosted numbers of muscle progenitor cells in the see-through fish as they developed.
The Zon Lab's earlier work with zebrafish led to a drug derived from prostaglandin that expands numbers of blood stem cells and is now in a Phase II clinical trial. But this time, researchers genetically modified the fish so that newly created muscle progenitor cells would show up in fluorescent green, and muscle fibers in red. This enabled the team to rapidly quantify muscle cells and fibers produced under different conditions, based on visual readouts—without having to examine each well's contents through laborious biochemical techniques.
"Automated imagers can take a picture to assay all the 384 wells within a matter of a week, as compared with several months with our earlier technique," says Zon, who is also a member of Boston Children's Division of Hematology/Oncology as well as the Harvard Stem Cell Institute (HSCI).
#2: Mice
The zebrafish tests revealed six compounds that expanded numbers of skeletal muscle progenitor cells. The Zon Lab collaborated with Amy Wagers, PhD, of HSCI and the Joslin Diabetes Center, and C. Ronald Kahn, MD, of Joslin to conduct experiments in a mouse model of Duchenne muscular dystrophy. "One of our chemicals, forskolin, also increased engraftment of progenitors into the muscles of the mice," Zon says. "We found you could get more muscle mass just by making more progenitors."
(Forskolin, though not approved by the FDA, has been used since ancient times to treat a variety of disorders and is sold as a dietary supplement.)
3# Patient-specific cells
Zon, Wagers, Kahn and colleagues next turned to human cells in a dish, working with induced pluripotent stem cells (iPS cells) made from the skin cells of patients with Duchenne muscular dystrophy. "Many muscle diseases could not be adequately modeled in iPS cells in the past," notes Zon. "No one's been able to get iPS cells to form skeletal muscle."
The researchers found that a combination of three small molecules (forskolin, basic fibroblast growth factor and a glycogen synthase kinase-3 GSK-3beta inhibitor) was able to reprogram iPS cells into muscle cells that successfully engrafted in mice.
Zon's next goal is to transplant these muscle cells from the dish into patients through clinical trials he hopes develop within the next several years. He may begin by trying to increase muscle mass in a specific anatomic location, but for a condition like Duchenne muscular dystrophy, he envisions a series of local injections in different parts of the body.
Broader applications
Zon believes that the combination of rapid zebrafish screening with patient-specific iPS cells will greatly speed up therapeutic development, allowing scientists to quickly vet large numbers of compounds and possible culture conditions. They can then enter a much shorter list of compounds into lengthier testing in human iPS cells that recapitulate the disease in question, as well as live mouse models.
"It's been very hard to figure out the conditions for making different tissues with iPS cells," Zon says. "We've created a very fast system to find what chemicals you need. Because it's so fast, we don't need a hypothesis to do an experiment—you can just do the screen, find the result and see what warrants pursuing."
The zebrafish system can also quickly spot inhibitors of tissue growth; in fact, it grew out of the lab's desire to find chemicals that blocked muscle development to treat rhabdomyosarcoma, a tumor that grows in skeletal muscle. The Zon Lab is also using it to find chemicals that can block expansion of melanocytes, potentially halting melanoma.
Using these technologies, the Zon Lab has developed and filed a patent on a platform for large-scale chemical screening in zebrafish. The lab has also benefited from funding from the Massachusetts Life Sciences Center.
INFORMATION:
Cong Xu of HSCI and Boston Children's Hospital, Mohammadsharif Tabebordbar of HSCI and Harvard University, and Salvatore Iovino of the Joslin Diabetes Center and Harvard Medical School shared first authorship of the paper. Funders included the National Institutes of Health (NIH #5P30 DK49216-19, #5R01CA103846-10, #DP2OD004345, #UO1HL100402, #DK31036), the Harvard Stem Cell Institute and the Howard Hughes Medical Institute. Zon is a founder and stockholder of Fate, Inc. and a scientific advisor for Stemgent.
Boston Children's Hospital is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including seven members of the National Academy of Sciences, 14 members of the Institute of Medicine and 14 members of the Howard Hughes Medical Institute comprise Boston Children's research community. Founded as a 20-bed hospital for children, Boston Children's today is a 395-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Boston Children's is also the primary pediatric teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Boston Children's, visit: http://vectorblog.org.
[Note to reporters: A color image of muscle tissue developing in zebrafish is available on request.]
Researchers build muscle in diseased mice; create human muscle cells in a dish
New zebrafish technique quickly finds potential treatments for multiple diseases
2013-11-07
ELSE PRESS RELEASES FROM THIS DATE:
A bio patch that can regrow bone
2013-11-07
A bio patch that can regrow bone
Potential uses for dental, from implants to craniofacial defects
Researchers at the University of Iowa have created a bio patch to regenerate missing or damaged bone by putting DNA into a nano-sized particle that delivers bone-producing ...
Grandiose narcissism reflects US presidents' bright and dark sides
2013-11-07
Grandiose narcissism reflects US presidents' bright and dark sides
Narcissus, the physically flawless character of Greek mythology who wound up falling in love with his own reflection, hardly seems like a good role model. For those dreaming of becoming president ...
Carnegie Mellon researchers use inkblots to improve security of online passwords
2013-11-07
Carnegie Mellon researchers use inkblots to improve security of online passwords
GOTCHA scheme could foil growing problem of automated brute force attacks
PITTSBURGH—Carnegie Mellon University computer scientists have developed a new password system that incorporates ...
Researchers regrow hair, cartilage, bone, soft tissues
2013-11-07
Researchers regrow hair, cartilage, bone, soft tissues
Enhancing cell metabolism was an unexpected key to tissue repair
Young animals are known to repair their tissues effortlessly, but can this capacity be recaptured in adults? A new study from researchers ...
Calcium and vitamin D improve bone density in patients taking antiepileptic drugs
2013-11-07
Calcium and vitamin D improve bone density in patients taking antiepileptic drugs
A recent prospective, randomized, placebo-controlled clinical trial reports that calcium and vitamin D supplementation improves bone density in a group of male veterans with epilepsy who were treated ...
Obesity may limit overall function 2 years after shoulder replacement surgery
2013-11-07
Obesity may limit overall function 2 years after shoulder replacement surgery
Obesity does not significantly impact short-term complications, outcomes
Rosemont, Ill. –Patients with obesity undergo a disproportionately higher number of elective ...
Blocking the active site of thiolase
2013-11-07
Blocking the active site of thiolase
This news release is available in German.
Scientists at the University of Oulu, Finland, and at the Helmholtz Center Berlin (HZB) have shown the way to new directions ...
Online course improves physicians skill level for detecting skin cancer
2013-11-07
Online course improves physicians skill level for detecting skin cancer
DETROIT – Primary care physicians who took an online training course about skin cancer detection significantly improved their skill to properly diagnose and manage benign and malignant ...
Vitamin C could ease muscle fatigue in chronic obstructive pulmonary disease patients
2013-11-07
Vitamin C could ease muscle fatigue in chronic obstructive pulmonary disease patients
Bethesda, Md. (Nov. 7, 2013)—Chronic obstructive pulmonary disease—a health problem in which the lungs lose their inherent springiness, making it progressively harder to breathe—can ...
1 worm, 2 mouths
2013-11-07
1 worm, 2 mouths
A devious evolutionary path between genetics and environment
Depending on the environment in which the worm grows, the larva of the roundworm Pristionchus pacificus develops into either a wide-mouthed predator or a narrow-mouthed bacteria ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Researchers build muscle in diseased mice; create human muscle cells in a dishNew zebrafish technique quickly finds potential treatments for multiple diseases